calendar
18,993 catalysts · 18,987 approval · 5,000 device 510k · 4,728 grant · 4,015 phase readout · 2,171 8k filing · 2,000 device pma
18,993 catalysts · 18,987 approval · 5,000 device 510k · 4,728 grant · 4,015 phase readout · 2,171 8k filing · 2,000 device pma
Sponsor: SAPTALIS PHARMS. Form: CONCENTRATE. Route: ORAL
Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION
Sponsor: BARR. Form: TABLET. Route: ORAL
Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL
Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION
Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: OTSUKA ICU MEDCL. Form: INJECTABLE. Route: INJECTION
Sponsor: OTSUKA ICU MEDCL. Form: INJECTABLE. Route: INJECTION
Sponsor: OTSUKA ICU MEDCL. Form: INJECTABLE. Route: INJECTION
Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL
Sponsor: PFIZER. Form: TABLET. Route: ORAL
Sponsor: PH HEALTH. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Sponsor: PHARMOBEDIENT. Form: SYRUP. Route: ORAL
Sponsor: XTTRIUM. Form: SOLUTION. Route: TOPICAL
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: EUROFARMA. Form: CREAM. Route: TOPICAL
Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION
Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION
Sponsor: SAPTALIS PHARMS. Form: CONCENTRATE. Route: ORAL
Sponsor: NOVEL LABS INC. Form: TABLET. Route: ORAL
Sponsor: PHARMACIA AND UPJOHN. Form: INJECTABLE. Route: INJECTION
Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL
Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL
Sponsor: WATSON LABS. Form: TABLET. Route: ORAL
Sponsor: PHARMACIA AND UPJOHN. Form: INJECTABLE. Route: INJECTION
Sponsor: B BRAUN. Form: SOLUTION. Route: IRRIGATION
Sponsor: ABBVIE ENDOCRINE INC. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: B BRAUN. Form: SOLUTION. Route: IRRIGATION
Sponsor: HIKMA. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: TEVA BRANDED PHARM. Form: TABLET. Route: ORAL
Sponsor: OTSUKA ICU MEDCL. Form: INJECTABLE. Route: INJECTION
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: ABBVIE. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: ACTAVIS MID ATLANTIC. Form: SYRUP. Route: ORAL
Sponsor: CHARTWELL RX. Form: SYRUP. Route: ORAL
Sponsor: HIKMA INTL PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: OTSUKA ICU MEDCL. Form: INJECTABLE. Route: INJECTION
Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL
Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION
Sponsor: PHARMOBEDIENT. Form: CAPSULE. Route: ORAL
Sponsor: HIKMA. Form: SYRUP. Route: ORAL
Sponsor: NOVEL LABS INC. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION
Sponsor: ANIMA. Form: SYRUP. Route: ORAL
Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION
Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION
Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION